Clinical Outcome of Patients Treated With 3D Conformal Radiation Therapy (3D-CRT) for Prostate Cancer on RTOG 9406
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation
Reference25 articles.
1. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406;Michalski;Int J Radiat Oncol Biol Phys,2000
2. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose level V;Michalski;Int J Radiat Oncol Biol Phys,2005
3. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV;Michalski;Int J Radiat Oncol Biol Phys,2004
4. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy);Ryu;Int J Radiat Oncol Biol Phys,2002
5. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer;Roach;J Urol,1993
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Creation, evolution, and future challenges of ion beam therapy from a medical physicist’s viewpoint (Part 3): Chapter 3. Clinical research, Chapter 4. Future challenges, Chapter 5. Discussion, and Conclusion;Radiological Physics and Technology;2023-10-26
2. Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity;Cancers;2023-02-13
3. Targeted Radiation and Immune Therapies—Advances and Opportunities for the Treatment of Prostate Cancer;Pharmaceutics;2023-01-11
4. Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126;Cancer;2022-12-29
5. A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome;Frontiers in Oncology;2022-04-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3